Drug and Therapeutics Bulletin 1995;33:77-79; doi:10.1136/dtb.1995.331077
Copyright © 1995 by the BMJ Publishing Group Ltd.

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Search for Related Content PubMed PubMed Citation

Giving erythromycin by mouth

Relevant BNF section: 5.1.5

Erythromycin is a broad spectrum macrolide antibiotic. In the UK, it is available in over 15 oral preparations, presented as tablets, capsules, suspensions or granules containing the drug as erythromycin base, as the stearate salt, or as an ester. How the drug is formulated affects the absorption and bioavailability of erythromycin, so could in theory influence its effectiveness and the incidence of unwanted effects. We review the different oral preparations and consider whether the choice of formulation matters in practice.

This article has been cited by other articles:

				C. A. M. McNulty, A. Kane, C. J. W. Foy, J. Sykes, P. Saunders, and K. A. V. Cartwright Primary care workshops can reduce and rationalize antibiotic prescribing J. Antimicrob. Chemother., September 1, 2000; 46(3): 493 - 499. [Abstract] [Full Text] [PDF]